Ibi -

For individuals with complex, chronic conditions like RA, finding the right treatment can be a long and difficult journey. Many are facing high costs due to cost sharing for premiums, deductibles, and Rx out-of-pocket (OOP) amounts. Manufacturers offer commercial co-pay assistance, but there are financial limits to this help. Programs are being offered to reverse application of this assistance from a member’s deductible, but that process can result in a financial burden to members. It has been shown that when some members face higher cost sharing for their medications, they become non-adherent to their therapy. For some patients, medication non-adherence has been associated with increased utilization of costly health care services such as emergency room (ER) visits and hospitalizations. Other strategies exist that can help members stay on treatment as prescribed.

 


 
 
Related Posts
    Current or Archive

    see all topics
    Tags

    see all topics
    Keyword Search
      IBI's 2025 Research Priorities
      Dec 12, 2024
      The Power of Appreciation on Employee Appreciation Day and International Women's Day
      Mar 28, 2024
      Navigating Disability and Productivity Challenges: Insights on Long COVID and Chronic Conditions
      Jan 30, 2024

      IBI Membership

      Sidebar-IBI-Membership

      Get access to the latest tools and research on health and productivity.

      IBI Tools

      Sidebar-IBI-Tools

      Use our resources and proprietary tools to turn data into action.